| Old Articles: <Older 27281-27290 Newer> |
|---|
 |
The Motley Fool
November 16, 2007
Alyce Lomax |
Charlotte Sometimes Beats Expectations The value-priced, fast-fashion, youth-oriented niche Charlotte Russe occupies, along with retailers like Forever 21 and H&M, is a good niche to be in at the moment.   |
BusinessWeek
November 26, 2007
Aaron Pressman |
If You Want to Play China... How do you play the white-hot China market without getting burned? Here are some ways. |
The Motley Fool
November 15, 2007
Anand Chokkavelu |
Rupert Murdoch Is Four Times Smart If Rupert Murdoch has his way, there will be no more $100 annual subscriptions to the Wall Street Journal's online edition. |
The Motley Fool
November 15, 2007
Toby Shute |
Secrets of the Sea Dry-bulk shipper Excel Maritime's third-quarter report is lacking disclosures to investors in several key areas. |
The Motley Fool
November 15, 2007
Toby Shute |
The Sweet Smell of Seismic Dawson Geophysical added three new seismic crews during the past fiscal year, boosting the company to a new record in revenues and profits. |
The Motley Fool
November 15, 2007
Chuck Saletta |
Dueling Fools: Marvel Bear Rebuttal The bearish opinion is that Marvel Entertainment cannot continue to leverage its famous superheroes indefinitely. |
The Motley Fool
November 15, 2007
Anders Bylund |
Dueling Fools: Marvel Bull The bulls feel that Marvel Entertainment is a lean, mean fighting machine that can make a mint off licensing its 5,000 character portfolio. |
The Motley Fool
November 15, 2007
Chuck Saletta |
Dueling Fools: Marvel Bear The bears feel that it's dangerous to look at Marvel Entertainment's recent straight-up growth trajectory and presume that it will continue into the future. |
The Motley Fool
November 15, 2007
Rich Smith |
Natuzzi Needs Reconditioning Italian sofa magnate Natuzzi reports a crushing 14% decline in the number of units sold during its fiscal 2007 third quarter. Investors, take note. |
The Motley Fool
November 15, 2007
Brian Orelli |
Slowing the Cash Burn Bloody Nose Nastech plans to cut costs following Proctor& Gamble's drop of their osteoporosis drug. Investors, take note. |
| <Older 27281-27290 Newer> Return to current articles. |
